Data Year:

For its 2024 fiscal year, ZOETIS INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In Biotechnology industry
Kristin C. Peck
Chief Executive Officer
Total Compensation $17,206,760 View details Pay Rank By Title In Biotechnology industry #29 View more
Wafaa Mamilli
Former EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health
Total Compensation $2,784,279 View details Pay Rank By Title In Biotechnology industry #8 View more
Wetteny Joseph
Executive Vice President ("EVP") and Chief Financial Officer
Total Compensation $5,089,461 View details Pay Rank By Title In Biotechnology industry #53 View more
Heidi C. Chen
Former EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics
Total Compensation $3,621,101 View details Pay Rank By Title In Biotechnology industry #18 View more
Robert J. Polzer
EVP and President of Research and Development
Total Compensation $2,973,038 View details Pay Rank By Title In Biotechnology industry #79 View more
Roxanne Lagano
EVP, General Counsel and Corporate Secretary
Total Compensation $2,615,155 View details Pay Rank By Title In Biotechnology industry #35 View more
Jamie Brannan
EVP and Chief Commercial Officer
Total Compensation $3,024,611 View details Pay Rank By Title In Biotechnology industry #77 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at ZOETIS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. ZOETIS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. ZOETIS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Kristin C. Peck
Chief Executive Officer
Total Cash $4,030,000 Equity $12,749,847 Other $426,913 $17,206,760
Wafaa Mamilli
Former EVP, Chief Digital and Technology Officer and Group President for China, Brazil and Precision Animal Health
Total Cash $1,273,740 Equity $1,379,557 Other $130,982 $2,784,279
Wetteny Joseph
Executive Vice President ("EVP") and Chief Financial Officer
Total Cash $1,747,500 Equity $3,187,315 Other $154,646 $5,089,461
Heidi C. Chen
Former EVP, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics
Total Cash $657,548 Equity $1,414,621 Other $1,548,932 $3,621,101
Robert J. Polzer
EVP and President of Research and Development
Total Cash $1,399,200 Equity $1,449,904 Other $123,934 $2,973,038
Roxanne Lagano
EVP, General Counsel and Corporate Secretary
Total Cash $1,248,208 Equity $1,249,679 Other $117,268 $2,615,155
Jamie Brannan
EVP and Chief Commercial Officer
Total Cash $1,411,546 Equity $1,214,615 Other $398,450 $3,024,611
For its 2024 fiscal year, ZOETIS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Kristin C. Peck CEO Pay $17,206,760 Median Employee Pay $79,134 CEO Pay Ratio 217:1
For its 2024 fiscal year, ZOETIS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Antoinette R. Leatherberry Total Cash $340,000
Frank A. D'Amelio Total Cash $357,500
Gavin D.K. Hattersley Total Cash $315,000
Gregory Norden Total Cash $365,000
Louise M. Parent Total Cash $370,000
Michael B. McCallister Total Cash $490,000
Paul M. Bisaro Total Cash $340,000
Robert W. Scully Total Cash $352,500
Sanjay Khosla Total Cash $340,000
Vanessa Broadhurst Total Cash $340,500
Willie M. Reed Total Cash $370,000
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.